Valuation: Integra LifeSciences Holdings Corporation

Market Cap 986M 876M 818M 745M 1.41B 94.8B 1.42B 9.9B 3.83B 48.46B 3.7B 3.62B 156B P/E 2026 *
20x
P/E 2027 * 11.7x
Enterprise Value 2.48B 2.2B 2.05B 1.87B 3.53B 238B 3.56B 24.84B 9.63B 122B 9.29B 9.09B 390B EV / Sales 2026 *
1.49x
EV / Sales 2027 * 1.32x
Free-Float
72.32%
Yield 2026 *
-
Yield 2027 * -
1 day-21.19%
1 week-21.34%
Current month-22.11%
1 month-22.87%
3 months-29.75%
6 months+33.05%
Current year+2.09%
1 week 12.63
Extreme 12.63
16.76
1 month 12.63
Extreme 12.63
16.76
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
74.98
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 2026-04-30
Director of Finance/CFO 54 2023-06-27
Chief Tech/Sci/R&D Officer - 2026-02-16
Director TitleAgeSince
Chairman 64 2012-01-02
Director/Board Member 81 1991-12-31
Director/Board Member 65 2005-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/17/26 Other

Company Secretary

26,838 0.0345%
9/1/26 Tax

Head of Human Resources

-1,455 0.0019%
7/3/26 Tax

Chief Financial Officer

-5,226 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
-21.19%-21.34%-14.32%-66.38% 986M
+0.84%-3.74%-27.56%+1.79% 169B
-0.07%-2.55%-11.59%+12.86% 110B
+0.90%+1.13%-25.66%+3.60% 106B
-1.24%-0.76%-49.50%-12.08% 73.87B
-0.24%+0.69%+2.08%+71.44% 58.98B
-0.86%+2.96%+12.91%+61.58% 51.28B
-0.71%-3.82%-8.68%-31.71% 48.16B
+0.12%-0.17%-17.87%+21.91% 40.84B
-1.01%-1.45%+27.31%-6.14% 32.21B
Average -2.35%-2.91%-11.29%+5.69% 69.12B
Weighted average by Cap. -0.01%-1.32%-17.07%+11.12%

Financials

2026 *2027 *
Net sales 1.67B 1.48B 1.38B 1.26B 2.37B 160B 2.4B 16.71B 6.48B 81.83B 6.25B 6.12B 263B 1.72B 1.53B 1.43B 1.3B 2.45B 165B 2.48B 17.27B 6.69B 84.58B 6.46B 6.32B 271B
Net income 49.25M 43.76M 40.84M 37.23M 70.21M 4.73B 70.86M 494M 192M 2.42B 185M 181M 7.77B 78.69M 69.92M 65.26M 59.48M 112M 7.56B 113M 790M 306M 3.87B 295M 289M 12.41B
Net Debt 1.49B 1.32B 1.24B 1.13B 2.12B 143B 2.14B 14.95B 5.79B 73.19B 5.59B 5.47B 235B 1.28B 1.14B 1.07B 971M 1.83B 124B 1.85B 12.89B 5B 63.15B 4.82B 4.72B 203B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
26-10-02 US$12.68 -21.19% 2,695,971
26-10-01 US$16.09 -1.17% 652,935
26-09-30 US$16.28 -2.16% 768,910
26-09-29 US$16.64 +2.27% 1,005,200
26-09-28 US$16.27 +0.93% 479,048
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
12.68USD
Average target price
18.88USD
Spread / Average Target
+48.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock